Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01076543
Title Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Chicago Illinois 60611 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Decatur Memorial Hospital Decatur Illinois 62526 United States Details
Ingalls Memorial Hospital Harvey Illinois 60426 United States Details
Illinois CancerCare-Peoria Peoria Illinois 61615 United States Details
Central Illinois Hematology Oncology Center Springfield Illinois 62702 United States Details
Southern Illinois University School of Medicine Springfield Illinois 62702 United States Details
Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne Indiana 46845 United States Details
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Mercy Hospital Saint Louis Saint Louis Missouri 63141 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field